A randomized controlled trial (RCT) comparing best supportive care (BSC), 5-FU plus folinic acid (FUFA) and, gemcitabine plus oxaliplatin (Gem-Ox) in management of unresectable gallbladder cancer (GBC)
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: A. D. Dwary, A. Sharma, B. K. Mohanti, S. Pal, P. Garg, V. Raina, N. K. Shukla, S. V. Deo, S. Thulkar, V. Sreenivas
Institution: All India Institute of Medical Sciences
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2248095073